Northwestern University Sues Moderna Over Spikevax Vaccine
Northwestern University alleges Moderna infringed on patents related to mRNA vaccine delivery technology developed at the university, prompting a lawsuit.
As bird flu spreads in cows, US close to funding Moderna's mRNA H5 vaccine
The US government is considering funding late-stage trials for Moderna's mRNA pandemic bird flu vaccine to bolster its pandemic jab stockpile.
Two-in-one flu and Covid jab passes advanced trial
Moderna's combined flu and Covid vaccine shows promising results in phase-three trials, offering convenience with one shot for both diseases.
US prepares for bird flu pandemic with $176M Moderna vaccine deal
The US government will pay Moderna $176 million to develop an mRNA vaccine for pandemic influenza amid the spread of H5N1 in US dairy cattle.
Northwestern University Sues Moderna Over Spikevax Vaccine
Northwestern University alleges Moderna infringed on patents related to mRNA vaccine delivery technology developed at the university, prompting a lawsuit.
As bird flu spreads in cows, US close to funding Moderna's mRNA H5 vaccine
The US government is considering funding late-stage trials for Moderna's mRNA pandemic bird flu vaccine to bolster its pandemic jab stockpile.
Two-in-one flu and Covid jab passes advanced trial
Moderna's combined flu and Covid vaccine shows promising results in phase-three trials, offering convenience with one shot for both diseases.
US prepares for bird flu pandemic with $176M Moderna vaccine deal
The US government will pay Moderna $176 million to develop an mRNA vaccine for pandemic influenza amid the spread of H5N1 in US dairy cattle.
What to know about Moderna's combined covid-flu vaccine on the horizon
Moderna's combined coronavirus-influenza vaccine triggers higher immune response in older adults, expected to improve coverage and accessibility by fall 2025.
Moderna's combination COVID-19/influenza shot showed better immune responses than separate vaccines.
Summer COVID Wave Prompts Early Emergency Approval of New Vaccines
The FDA has approved updated vaccines from Pfizer and Moderna to combat the KP.2 COVID-19 strain amid severe summer infections.
Medicine is going personalised': Moderna's UK boss on the coming vaccine revolution
Pfizer's former UK vaccine leader is now overseeing the construction of Moderna's manufacturing and research center in Oxfordshire.
The Moderna site is dedicated to the production of mRNA vaccines against new Covid variants and other illnesses.
What to know about Moderna's combined covid-flu vaccine on the horizon
Moderna's combined coronavirus-influenza vaccine triggers higher immune response in older adults, expected to improve coverage and accessibility by fall 2025.
A Combined Flu and COVID-19 Shot May Be Coming
Moderna's combination COVID-19/influenza shot showed better immune responses than separate vaccines.
I thought I had Covid - it was another, unbearably painful, disease'
HIV patient contracts monkeypox, describes the painful experience.
Encouraging participation in mpox vaccine trials for potential life-changing impact.
Here's why Pfizer, Moderna COVID vaccines do not affect DNA, experts say
Florida Surgeon General Joseph Ladapo is facing criticism from federal regulators for spreading unfounded safety concerns about Pfizer and Moderna's COVID-19 vaccines.
Ladapo claims that the vaccines could potentially affect people's DNA and raise concerns about a possible cancer risk, but the FDA and vaccine experts have dismissed his claims.
Moderna's vaccine helped fight COVID. Here's what's coming in its next wave of mRNA drugs
Moderna's pipeline of mRNA-based vaccine candidates could yield five new marketed products by 2026, according to a new analyst report from Oppenheimer.
Some of the experimental products in Moderna's pipeline include an influenza vaccine, a combination flu and COVID vaccine, an RSV vaccine, and an experimental cancer vaccine for melanoma.
Moderna soars on analyst upgrade | Entrepreneur
Moderna saw a 13% stock surge after an analyst upgraded the stock and predicted five product approvals by 2026.
Despite a challenging 2023, Moderna's future growth relies on its diverse pipeline of new products.
Merck-Moderna vaccine cuts odds of skin cancer recurrence in half, study finds
A vaccine developed by Moderna and Merck shows promising results in treating the most deadly form of skin cancer.
Those who received the vaccine and Merck's cancer drug Keytruda were 49% less likely to die or have their cancer come back after three years.
Opinion | The Covid Vaccine Windfall Turns on Pfizer and Moderna
Pfizer and Moderna's stock prices surged during the Covid panic
Pfizer became the first pharmaceutical company to have over $100 billion in annual sales in 2022
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
Moderna's combo flu and COVID vaccine generates a strong immune response in older adults, potentially offering a promising solution in combating respiratory illnesses.